home.social

#wegovy — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #wegovy, aggregated by home.social.

  1. 法國宣佈國民將可以向國家醫保申請報銷使用減肥藥 的開支,是歐盟首個國家這樣做

    新措施6月中生效,預計每年花1億歐元公帑

    europechinese.blogspot.com/202

  2. France becomes first EU country to reimburse anti-obesity drugs

    France ⁠will reimburse the cost of weight-loss drugs prescribed to severely obese patients from mid-June in a first…
    #Europe #EU #Anti-obesitydrugs #EliLilly #EuropeanMedicinesAgency #EuropeanUnion #France #Mounjaro #NovoNordisk #TF1 #US #Wegovy #weight-lossdrugs
    europesays.com/europe/54593/

  3. europesays.com/dk/92490/ Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1) #JacobMartin #NovoNordisk #Obesity #Type2Diabetes #Wegovy #WeightLoss

  4. ‘Natural Wegovy’ egg recipe stirs weight-loss buzz in Korea

    Screenshots of Instagram search results for “natural Wegovy” in Korean (Instagram) While the use of weight-loss injections such as Wegovy and Mounjaro grows in Korea, some people looking for cheaper ways to curb …
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #Korea #Mediterranean #mounjaro #obease #Ojempic #Olive #wegovy
    diningandcooking.com/2658378/n

  5. ‘Natural Wegovy’ egg recipe stirs weight-loss buzz in Korea

    Screenshots of Instagram search results for “natural Wegovy” in Korean (Instagram) While the use of weight-loss injections such as Wegovy and Mounjaro grows in Korea, some people looking for cheaper ways to curb …
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #Korea #Mediterranean #mounjaro #obease #Ojempic #Olive #wegovy
    diningandcooking.com/2658378/n

  6. ‘Natural Wegovy’ egg recipe stirs weight-loss buzz in Korea

    Screenshots of Instagram search results for “natural Wegovy” in Korean (Instagram) While the use of weight-loss injections such as Wegovy and Mounjaro grows in Korea, some people looking for cheaper ways to curb …
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #Korea #Mediterranean #mounjaro #obease #Ojempic #Olive #wegovy
    diningandcooking.com/2658378/n

  7. ‘Natural Wegovy’ egg recipe stirs weight-loss buzz in Korea

    Screenshots of Instagram search results for “natural Wegovy” in Korean (Instagram) While the use of weight-loss injections such as Wegovy and Mounjaro grows in Korea, some people looking for cheaper ways to curb …
    #dining #cooking #diet #food #MediterraneanOliveOil #OliveOil #Korea #Mediterranean #mounjaro #obease #Ojempic #Olive #wegovy
    diningandcooking.com/2658378/n

  8. ‘Natural Wegovy’ egg recipe stirs weight-loss buzz in Korea

    Screenshots of Instagram search results for “natural Wegovy” in Korean (Instagram) While the use of weight-loss injections such as Wegovy and Mounjaro grows in…
    #dining #cooking #diet #food #mediterranean #MediterraneanDiet #MediterraneanFood #MediterraneanOliveOil #OliveOil #Korea #Mediterranean #mounjaro #obease #Ojempic #Olive #wegovy
    diningandcooking.com/2658378/n

  9. ‘Natural Wegovy’ egg recipe stirs weight-loss buzz in Korea

    Screenshots of Instagram search results for “natural Wegovy” in Korean (Instagram) While the use of weight-loss injections such as Wegovy and Mounjaro grows in…
    #dining #cooking #diet #food #mediterranean #MediterraneanDiet #MediterraneanFood #MediterraneanOliveOil #OliveOil #Korea #Mediterranean #mounjaro #obease #Ojempic #Olive #wegovy
    diningandcooking.com/2658378/n

  10. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  11. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  12. DATE: May 25, 2026 at 09:39AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover why Ozempic and Wegovy weight loss eventually plateaus

    URL: sciencedaily.com/releases/2026

    New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone. Scientists also found a possible way to extend the drugs’ effects, potentially helping patients push past weight-loss plateaus.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    DAILY EMAIL DIGEST: Email [email protected] -- no subject or message needed.

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot

    Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: nationalpsychologist.com

    EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE: subscribe-article-digests.clin

    READ ONLINE: read-the-rss-mega-archive.clin

    It's primitive... but it works... mostly...

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #Ozempic #Wegovy #Semaglutide #WeightLossPlateau #GLP1 #AppetiteControl #NIHResearch #WeightLossScience #DrugDevelopment #HealthNews

  13. Generic semaglutide to hit Canadian pharmacies this week at lower cost

    Two generic versions of Ozempic and Wegovy are set to start arriving in Canadian pharmacies this week, which…
    #NewsBeep #News #Medication #Consumer #GLP-1 #Health #Ozempic #Semaglutide #UK #UnitedKingdom #Wegovy #weight-lossdrugs
    newsbeep.com/uk/602216/

  14. europesays.com/dk/90414/ Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class #A/S #Approval #as #by #CHMP #Class #efficacious #EU #First #for #GLP1 #in #Its #most #Nordisk #novo #NovoNordisk #Obesity #Oral #pill #Recommended #representing #semaglutide #the #Treatment #Wegovy

  15. europesays.com/dk/90147/ Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1) #1 #207% #72 #A #A/S #Approval #CHMP #EU #in #Loss #mean #mg #Nordisk #novo #NovoNordisk #of #pen #providing #recommends #SingleDose #to #Up #Wegovy #Weight

  16. europesays.com/dk/89935/ Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1) #JacobMartin #NovoNordisk #Obesity #Type2Diabetes #Wegovy #WeightLoss

  17. Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)

    Novo Nordisk A/S Wegovy® 7.2 mg in a single-dose pen has now been recommended by CHMP for approval…
    #Europe #EU #EuropeanUnion #JacobMartin #NovoNordisk #Obesity #type2diabetes #Wegovy #weightloss
    europesays.com/europe/50464/

  18. europesays.com/dk/89839/ Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class #CardiovascularEvents #DrugRestrictions #ExcessBodyWeight #JacobMartin #NovoNordisk #oasis #Obesity #OralTreatment #Wegovy #WeightLoss #WeightManagement

  19. europesays.com/dk/89675/ Novo Nordisk A/S: Wegovy® pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class #CardiovascularEvents #DrugRestrictions #ExcessBodyWeight #JacobMartin #NovoNordisk #oasis #Obesity #OralTreatment #Wegovy #WeightLoss #WeightManagement